CUAMC
VYGR icon

China Universal Asset Management Company’s Voyager Therapeutics VYGR Stock Holding History

China Universal Asset Management Company’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.7K Sell
9,616
-842
-8% -$3.19K ﹤0.01% 480
2026
Q1 		$40.4K Buy
10,458
+855
+9% +$3.37K ﹤0.01% 469
2025
Q4 		$37.7K Sell
9,603
-120
-1% -$531 ﹤0.01% 466
2025
Q3 		$45.4K Sell
9,723
-1,391
-13% -$5.03K ﹤0.01% 440
2025
Q2 		$34.6K Buy
11,114
+157
+1% +$506 ﹤0.01% 438
2025
Q1 		$37K Sell
10,957
-626
-5% -$2.92K ﹤0.01% 436
2024
Q4 		$65.7K Buy
11,583
+1,094
+10% +$7.05K 0.01% 434
2024
Q3 		$61.4K Buy
10,489
+4,098
+64% +$29.8K 0.01% 381
2024
Q2 		$50.6K Sell
6,391
-4,013
-39% -$33.6K 0.01% 356
2024
Q1 		$96.9K Buy
10,404
+5,311
+104% +$44.8K 0.01% 375
2023
Q4 		$43K Buy
+5,093
New +$36.9K 0.01% 383

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

China Universal Asset Management Company's VYGR Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Voyager Therapeutics (VYGR) stake by 8.1% in Q2 2026, selling an estimated $3.19K and leaving 9,616 shares worth $33.7K. The position accounts for ﹤0.01% of the portfolio, ranked #480.

China Universal Asset Management Company first reported a position in VYGR in Q4 2023 and has held it in 11 quarters since. The position peaked at $96.9K in Q1 2024. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • China Universal Asset Management Company held 9,616 shares of Voyager Therapeutics worth $33.7K as of Q2 2026.
  • China Universal Asset Management Company sold 842 Voyager Therapeutics shares in Q2 2026, an estimated $3.19K.
  • Voyager Therapeutics made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #480 holding.
  • China Universal Asset Management Company first reported a position in Voyager Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • China Universal Asset Management Company's Voyager Therapeutics position peaked at $96.9K in Q1 2024.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.